The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
P O Box 4758
Scottsdale, AZ 85261
The Myeloproliferative Neoplasms Education Foundation (MPNEF) was founded in 2004 as a 501c3 organization run by MPN volunteers. It is focused in bringing education, information and support to MPN patients all over the world. This is achieved through MPN-NET, an un-moderated discussion list that addresses patient experiences, psychosocial issues, new research, clinical trials, current treatment practices and alternatives. They also provide educational videos about MPN, a newsletter, and they host a biannual patient conference in conjunction with the Mayo Clinic. MPN is a related group of hematological malignancies in which bone marrow cells responsible for producing red blood in the body malfunction. MPN's can also progress to an agressive blood cancer. Specific MPN conditions include Chronic Myelogenous Leukemia (CML), Essential Thrombocythemia (ET), Myelofibrosis (MF), and Polycythemia Vera (PV).
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.